首页> 外文期刊>Journal of periodontal research >Levels of tissue inhibitor of metalloproteinases-1 and matrix metalloproteinases-1 and -8 in gingival crevicular fluid following treatment with enamel matrix derivative (EMDOGAIN).
【24h】

Levels of tissue inhibitor of metalloproteinases-1 and matrix metalloproteinases-1 and -8 in gingival crevicular fluid following treatment with enamel matrix derivative (EMDOGAIN).

机译:牙釉质基质衍生物(EMDOGAIN)治疗后牙龈沟液中金属蛋白酶-1和基质金属蛋白酶-1和-8的组织抑制剂水平。

获取原文
获取原文并翻译 | 示例
           

摘要

The mechanism of enamel matrix derivative (EM D) action on the periodontal wound healing process is not well understood. However, earlier in vitro studies from our laboratory demonstrated that EMD stimulated the proliferation of both periodontal ligament and gingival fibroblast cells. Therefore, the purpose of this study was to further evaluate the effect of EMD on the early wound healing process by assessing the protein levels of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in gingival crevicular fluid (GCF). Sixteen patients, each of whom had one or two pairs of infrabony defects located contralaterally in the same arch, were included in this clinical trial. Thirty-six infrabony defects were randomly assigned treatment with flap surgery plus EMD or flap surgery plus placebo. At baseline and at 2, 4 and 12 week follow-up evaluation visits, GCF was sampled with paper strips. After determination of GCF volume, TIMP-1, MMP-1 and MMP-8 GCF levels were measured by an enzyme-linked immunosorbent assay. Intragroup analysis: At week 2 following surgery, when compared to baseline all parameters in each study group, except MMP-1, significantly increased (p<0.05). There were no significant differences between 4 or 12 weeks and baseline in either study group. Intergroup analysis: At 4 weeks after surgery, GCF volume and TIMP-1 levels showed a significant decrease (p<0.05) in the EMD group, when compared to the placebo group. MMP-1 levels at weeks 2, 4 and 12, and MMP-8 levels at weeks 4 and 12 were significantly lower (p < 0.05) in the EMD group compared to the placebo group. EMD compared to placebo treated sites demonstrated a more rapid return to baseline levels of TIMP-1, MMP-1 and MMP-8. These findings suggest that treatment with flap surgery and EMD, compared to flap surgery with placebo, accelerated healing at an earlier stage of wound healing following surgery.
机译:牙釉质基质衍生物(EM D)对牙周伤口愈合过程的作用机理尚不十分清楚。但是,我们实验室的早期体外研究表明,EMD刺激牙周膜和牙龈成纤维细胞的增殖。因此,本研究的目的是通过评估牙龈沟液(GCF)中基质金属蛋白酶(MMPs)和金属蛋白酶组织抑制剂(TIMPs)的蛋白水平来进一步评估EMD对伤口早期愈合的影响。该临床试验包括16名患者,每个患者的对侧位于同一个牙弓中有一对或两对骨下缺损。皮瓣手术加EMD或皮瓣手术加安慰剂随机分配36例骨下缺损。在基线以及第2、4和12周的随访评估访问中,用纸条对GCF进行了采样。在确定GCF体积之后,通过酶联免疫吸附测定法测量TIMP-1,MMP-1和MMP-8 GCF水平。组内分析:术后第2周,与基线相比,每个研究组中除MMP-1外的所有参数均显着增加(p <0.05)。在任何一个研究组中,第4周或第12周与基线之间均无显着差异。组间分析:与安慰剂组相比,EMD组术后4周GCF量和TIMP-1水平显着降低(p <0.05)。与安慰剂组相比,EMD组第2、4和12周的MMP-1水平以及第4和12周的MMP-8水平显着降低(p <0.05)。与安慰剂治疗的部位相比,EMD显示TIMP-1,MMP-1和MMP-8的基线水平恢复更快。这些发现表明,与使用安慰剂进行皮瓣手术相比,使用皮瓣手术和EMD进行治疗可在术后伤口愈合的早期加速愈合。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号